Clinical survey of MS Contin in the treatment of acute myocardial infarction
- VernacularTitle:美施康定治疗急性心肌梗死的临床观察
- Author:
Ruihua CHEN
;
Jiming XIAO
- Publication Type:Journal Article
- Keywords:
MS -contin;
Acute myocardial infaction
- From:
Journal of Medical Postgraduates
2005;0(S1):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To assess the therapeutic effects and adverse reactions of MS Contin in the treatment of acute myocardial infarction (AMI). Methods: 42 AMI patients were divided into experiment group and control group. Experiment group were given oral administration of MS Contin for 1 week besides the routine treatment of AMI for patients in the control group. Results: Between the two groups, the differences in the product of heart rate and blood pressure ( HR?BP) , the frequency of angina pecto-ris attack, the recovery time of the ST segment and the incidence of acute arrhythmia were significant. The most common side effects observed were: vomiting, constipation, hallucination, and the most severe toxic side effect was respiratory inhibition. Conclusion : In the treatment of AMI, MS Contin could relieve the pain effectively, reduce the incidence of angina pectoris attack and severe arrhythmia, decrease myocardial oxygen consumption, have tolerable side effects in the majority of patients. It is preferable to use MS Contin as a concurrent treatment of AMI.
